Least Invasive

Enteromedics

 



EnteroMedics
® Inc. has developed VBLOC® vagal blocking therapy, a first-in-class weight loss treatment for obesity and related co-morbidities. VBLOC Therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, is designed to control both hunger and fullness by blocking the primary nerve which regulates the digestive system. VBLOC Therapy is designed to address the lifelong challenge of obesity by empowering people to take a positive path toward weight loss without compromising their lifestyle. read more

 

 

 

 

 

 

 

المؤتمر العلمي الثامن للجمعية السعودية للجراحة العامة

 

 

 

 

------------------------------------------------------------------------------------

Bariatric surgery in diabetes patients reduces vascular risks
Type 2 diabetes patients who had any type of bariatric surgery showed a 61% to 78% reduced risk of macrovascular, microvascular or vascular events compared with those who did not have surgery, data presented at the annual meeting of the Southern Surgical Association indicated. Read more...

--------------------------------------------------------------

 

 

 

To know more about VBLOC Maestro watch Dr. Osamah Al-Sanea Consultant Laparoscopic Bariatric & Endocrine Surgeon, CEO and Shief Surgeon in Royal Hayatt Hospital ( Kuwait ) On Al-Arabiya Channel ( Sabah Al-Arabiya Show ) - 9th June 2012

 

 

 

 

------------------------------------------------------------------------------------

EnteroMedics Announces First Commercial Shipment of the Maestro(R) Rechargeable System to Australia

EnteroMedics signs Middle East Distribution Agreement With BADER SULTAN & BROTHERS COMPANY W.L.L.;

Also you can read about it here 

 

BSBC launching the new VBloc Maestro® System at the AMESCON 2012-Dubai (14-17 March 2012)

Bader Sultan & Brothers Co. participated in the Asia Middle East Surgery Conference-2012 launching the latest of weight loss techniques in the middle east-VBloc Maestro® System.

 

Copyright © 2012 Body Contouring | Home | Sitemap| FAQ’s | Terms & Conditions | Contact Us